Date | Insider | Price | Amount |
---|---|---|---|
12-17-2015 Insider Buy |
Saverio Lafrancesca Chief Medical Officer |
$2.01 CAGR » |
$4,817.35 2,393 shares |
12-1-2015 Insider Buy |
John F. Kennedy Director |
$2.95 CAGR » |
$26,524.80 9,000 shares |
12-1-2015 Insider Buy |
Saverio Lafrancesca Chief Medical Officer |
$3.01 CAGR » |
$30,052.00 10,000 shares |
11-19-2015 Insider Buy |
Thomas McNaughton Chief Financial Officer |
$1.70 CAGR » |
$17,000.00 10,000 shares |
11-19-2015 Insider Buy |
James Joseph McGorry President and CEO |
$1.79 CAGR » |
$17,900.00 10,000 shares |
11-18-2015 Insider Buy |
Thomas McNaughton Chief Financial Officer |
$1.56 CAGR » |
$15,600.00 10,000 shares |
11-17-2015 Insider Buy |
David Green Director |
$1.34 CAGR » |
$33,500.00 25,000 shares |
11-17-2015 Insider Buy |
Thomas McNaughton Chief Financial Officer |
$1.32 CAGR » |
$19,800.00 15,000 shares |
11-17-2015 Insider Buy |
David Green Director |
$1.34 CAGR » |
$33,500.00 25,000 shares |
11-17-2015 Insider Buy |
Thomas McNaughton Chief Financial Officer |
$1.32 CAGR » |
$19,800.00 15,000 shares |
9-18-2015 Insider Buy |
Saverio Lafrancesca Chief Medical Officer |
$1.29 CAGR » |
$12,210.00 9,500 shares |
8-28-2015 Insider Buy |
Saverio Lafrancesca Chief Medical Officer |
$0.96 CAGR » |
$2,400.00 2,500 shares |
8-26-2015 Insider Buy |
Thomas McNaughton Chief Financial Officer |
$0.88 CAGR » |
$8,800.00 10,000 shares |
8-24-2015 Insider Buy |
John F. Kennedy Director |
$0.83 CAGR » |
$9,960.00 12,000 shares |
8-21-2015 Insider Buy |
James Joseph McGorry President and CEO |
$0.74 CAGR » |
$23,025.00 31,300 shares |
8-21-2015 Insider Buy |
Thomas McNaughton Chief Financial Officer |
$0.66 CAGR » |
$65,500.00 100,000 shares |
6-2-2015 Insider Buy |
James Joseph McGorry President and CEO |
$4.21 CAGR » |
$126,400.00 30,000 shares |
6-4-2015 Insider Buy |
John F. Kennedy Director |
$2.13 CAGR » |
$2,130.00 1,000 shares |
6-3-2015 Insider Buy |
Thomas McNaughton Interim CEO & CFO |
$1.85 CAGR » |
$29,670.00 16,000 shares |
6-3-2015 Insider Buy |
John F. Kennedy Director |
$1.95 CAGR » |
$1,950.00 1,000 shares |
6-3-2015 Insider Buy |
David Green Director |
$1.98 CAGR » |
$46,332.00 23,400 shares |
5-29-2015 Insider Buy |
Francesca Saverio La Chief Medical Officer |
$1.85 CAGR » |
$9,250.00 5,000 shares |
5-29-2015 Insider Buy |
Thomas McNaughton Interim CEO & CFO |
$1.91 CAGR » |
$9,550.00 5,000 shares |
6-1-2015 Insider Buy |
John F. Kennedy Director |
$1.67 CAGR » |
$16,700.00 10,000 shares |
6-2-2015 Insider Buy |
David Green Director |
$1.81 CAGR » |
$48,146.00 26,600 shares |
2-18-2015 Insider Buy |
David Green Chief Executive Officer |
$1.75 CAGR » |
$87,500.00 50,000 shares |
2-13-2015 Insider Buy |
Thomas McNaughton Chief Financial Officer |
$2.67 CAGR » |
$37,380.00 14,000 shares |
Also See: Institutional Holders of HART
Also See: SEC filings
Growth of $10,000.00 With Dividends Reinvested |
|||
Start date: | 01/14/2021 | ||
End date: | 05/07/2024 | ||
Start price/share: | $25.00 | ||
End price/share: | $30.17 | ||
Starting shares: | 399.94 | ||
Ending shares: | 415.47 | ||
Dividends reinvested/share: | $1.03 | ||
Total return: | 25.36% | ||
Average Annual Total Return: | 7.07% | ||
Starting investment: | $10,000.00 | ||
Ending investment: | $12,536.84 | ||
Years: | 3.31 | ||
Growth of $10,000.00 Without Dividends Reinvested |
|||
Start date: | 01/14/2021 | ||
End date: | 05/07/2024 | ||
Start price/share: | $25.00 | ||
End price/share: | $30.17 | ||
Dividends collected/share: | $1.03 | ||
Total return: | 24.81% | ||
Average Annual Total Return: | 6.93% | ||
Starting investment: | $10,000.00 | ||
Ending investment: | $12,482.67 | ||
Years: | 3.31 |
HART Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.), and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these categories, but instead file their holdings quarterly on the latest form 13F filings. While recent HART insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding HART
Free HART Email Alerts: Get Dividend Alerts Get SEC Filing Alerts |